Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations

Abstract

These findings suggest a small increase in the risk of cardiac malformations associated with intrauterine exposure to methylphenidate but not to amphetamines. This information is important when weighing the risks and benefits of alternative treatment strategies for attention-deficit/hyperactivity disorder in women of reproductive age and during early pregnancy.